Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

AMAZON COM INC (AMZN)

  • Business News
  • Sept. 15, 2026, 05:02 UTC
  • 1
  • 1 comments

Prime Big Deal Days is Back October 6-7, Kicking Off the Season with Two Days of Exclusive Savings for Prime Members

Market reaction Comment Full text

AMAZON COM INC (AMZN)

  • Business News
  • Sept. 15, 2026, 05:02 UTC
  • 1
  • 1 comments

Prime Big Deal Days regresa del 6 al 7 de octubre, dando inicio a la temporada con dos días de ahorros exclusivos para miembros Prime

Market reaction Comment Full text

SYSCO CORP (SYY)

  • Business News
  • Sept. 15, 2026, 04:18 UTC
  • 1
  • 1 comments

Sysco Announces Pricing of Common Stock Offering

Market reaction Comment Full text

TRIPADVISOR, INC. (TRIP)

  • Business News
  • Sept. 15, 2026, 04:01 UTC
  • 1
  • 1 comments

Tripadvisor Announces 2026 Travelers Choice Awards: Best of the Best Restaurants, Showcasing the Worlds Top Eateries & Experiences

Market reaction Comment Full text

EIGHTCO HOLDINGS INC. (ORBS)

  • Business News
  • Sept. 15, 2026, 03:52 UTC
  • 1
  • 1 comments

Bitmine Immersion Technologies (BMNR) annonce que ses avoirs en ETH (Ethereum) sélèvent à 5,96 millions de jetons, et que le total de ses avoirs en cryptomonnaies et en liquidités atteint 15,8 milliards de dollars

Market reaction Comment Full text

TERADYNE, INC (TER)

  • Business News
  • Sept. 15, 2026, 03:30 UTC
  • 1
  • 1 comments

Teradyne Opens Office in India, Deepening Commitment to the Country’s Growing Semiconductor Ecosystem

Market reaction Comment Full text

CELLEBRITE DI LTD. (CLBT)

  • Business News
  • Sept. 15, 2026, 03:02 UTC
  • 1
  • 1 comments

Cellebrite leitet Pläne für eine Verlegung des Firmensitzes in die Vereinigten Staaten ein

Market reaction Comment Full text

PBF ENERGY INC. (PBF)

  • Business News
  • Sept. 15, 2026, 03:02 UTC
  • 1
  • 1 comments

PBF Energy Announces Pricing of $500 Million of 0% Exchangeable Notes due 2032

Market reaction Comment Full text

Johnson & Johnson (JNJ)

  • Business News
  • Sept. 15, 2026, 03:00 UTC
  • 1
  • 1 comments

Johnson & Johnson - RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) plus LAZCLUZE® (lazertinib) with prophylactic strategies shows low rates of treatment-related events at WCLC 2026

Market reaction Comment Full text

Johnson & Johnson (JNJ)

  • Business News
  • Sept. 15, 2026, 03:00 UTC
  • 1
  • 1 comments

RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) plus LAZCLUZE® (lazertinib) with prophylactic strategies shows low rates of treatment-related events at WCLC 2026

Market reaction Comment Full text
  • Previous
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next

Search

News categories

  • Technical Exchange News(14812)
  • Event(6229)
  • SEC News(400537)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(243940)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin